Biom Qsystem®
Is the world’s firts biological treatment capable of treating anf preventing Xilella fastidiosa infections.
WHAT IS IT?
WHAT IS IT?
It is a disruptive, patented technology that acts on three different levels:
It interferes with and blocks bacterial communication, while gradually reducing the bacterial load.
It breaks down established biofilms and reopens the plant’s vascular channels
Restores plant health: significantly reduces symptoms and even recovers infected trees
Video created by Orbitia
BENEFITS
BENEFITS
Product’s differential values
- Contains no microorganisms
- Leaves no residue and is easy to use
- Applied by endotherapy*, ensuring biosafety and compatibility with organic farming standards
- This platform can be adapted to other bacterial pathogens, offering a pathway for future applications
- Patented technology (with the support of ACCIÓ) developed for industrial scaling
*For real-world trials, endotherapy bags (with patented system) from Fertinyect
RESULTS
RESULTS
Field validations demonstrated a curative response in olive trees (Apulia, Italy) and a significant reduction in bacterial load of more than 80% in almond trees (Mallorca, Spain*), highlighting the consistent curative performance of the product.
*Trials carried out in collaboration with the Institut de Recerca i Formació Agroalimentaria i Pesquera and the Laboratori Oficial de Sanitat Vegetal de les Illes Balears (LOSVIB), (Conselleria d’Agricultura, Pesca i Medi Natural del Govern de les Illes Balears)
BEFORE 1st treatment – August 2024

Clear symptoms of the disease on the tree branches before treatment
AFTER 1st treatment – November 2024

After the first treatment, a clear recovery of the tree can be observed
AFTER 2nd treatment – September 2025

The tree has significantly recovered its foliage mass
NUESTRAS NEWS
NUESTRAS NEWS
«BIOM da la bienvenida al nuevo socio inversor BEABLE CAPITAL»
Beable Capital cuenta con el apoyo del Centro para el Desarrollo Tecnológico Industrial (CDTI) a través de Innvierte Economia Sostenible SME S.A. y del Instituto de Crédito Oficial (ICO) a través de FONDICO GLOGAL FCR, ambas las principales instituciones públicas especializadas en promover la inversión de capital riesgo en el sector tecnológico español, lanzando nuevas empresas innovadoras o de base tecnológica (principalmente pequeñas y medianas empresas) y facilitando la participación estable del capital privado a largo plazo mediante la inversión en otras entidades de capital riesgo.
Concesión del SELLO de PYME INNOVADORA por el Ministerio de Ciencia e Innovación del Gobierno de España (12 de Junio de 2023)
Concesión NEOTEC 2022 para proyecto:
«DISEÑO Y DESARROLLO DE BIOMATERIALES PARA LA INDUSTRIA DE NUEVA GENERACIÓN»
Concesión “Ajuts per a incentivar el creixement de Start-Ups Tecnológicas 2020”
“Premi del Consell Social a la Transferencia de Coneixement 2019”


















